Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Exchange: BM&FBOVESPA
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Hypermarcas SA

+ Add to Watchlist

HYPE3:BZ

17.280 BRL 0.120 0.70%

As of 16:39:00 ET on 05/17/2013.

Snapshot for Hypermarcas SA (HYPE3)

Open: 17.330 Day's Range: 17.140 - 17.440 Volume: 2,149,500
Previous Close: 17.160 52wk Range: 9.820 - 18.370 1-Yr Rtn: +52.09%

Stock Chart for HYPE3

No chart data available.
  • HYPE3:BZ 17.280
  • 1D
  • 1M
  • 1Y
17.160
Interactive HYPE3 Chart

Previous Close

Key Statistics for HYPE3

Current P/E Ratio (ttm) 38.7673
Estimated P/E(12/2013) 26.7492
Relative P/E vs. IBOV -
Earnings Per Share (BRL) (ttm) 0.4457
Est. EPS (BRL) (12/2013) 0.6460
Est. PEG Ratio 1.1053
Market Cap (M BRL) 10,841.41
Shares Outstanding (M) 627.40
30 Day Average Volume 3,333,593
Price/Book (mrq) 1.5516
Price/Sale (ttm) 2.7478
Dividend Indicated Gross Yield 0.94%
Cash Dividend (BRL) 0.1630
Last Dividend 05/02/2013
5 Year Dividend Growth -
Next Earnings Announcement 08/02/2013
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HYPE3

  • Revenue
  • Net Income (M/BRL)
  • Profit Margin (%)

Company Profile & Key Executives for HYPE3

Hypermarcas SA manufactures and markets a wide range of consumer goods through its own proprietary brands in two sectors, pharmaceuticals and personal care. The Company's pharmaceuticals products are over-the-counter, generics and prescription medication. Hypermarcas also offers personal care products, such as health and beauty, diapers and other disposables.

Claudio Bergamo Dos SantosChief Executive OfficerMartim Prado MattosChief Financial Officer
Luiz Eduardo ViollandCEO:MedicinesNicolas FischerCEO:Consumer
More Company Profile & Key Executives for HYPE3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil